Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Pika Meško Brguljan"'
Publikováno v:
Zdravniški Vestnik, Vol 84, Iss 3 (2015)
BackgroundTherapeutic monitoring of theophylline serum levels is required due to its narrow therapeutic range and marked interindividual pharmacokinetic variability. We evaluated therapeutic drug monitoring service for theophylline in Slovenian clini
Externí odkaz:
https://doaj.org/article/10ee2f5538b24f45b5d39fb480eb6e6d
Publikováno v:
Zdravniški Vestnik, Vol 79, Iss 10 (2010)
Purpose of the Study: Clinical prediction models have been developed to assess the pre-test probability for pulmonary embolism (PE). The Wells model and the revised Geneva score are the two most well studied. Our purpose was to compare the two predic
Externí odkaz:
https://doaj.org/article/473ded069d694bb7a3919ba5dd3b64c1
Autor:
Florent J.L.A. Vanstapel, Matthias Orth, Thomas Streichert, Ettore D. Capoluongo, Wytze P. Oosterhuis, Hikmet Can Çubukçu, Francisco A. Bernabeu-Andreu, Marc Thelen, Leo H.J. Jacobs, Solveig Linko, Harjit Pal Bhattoa, Patrick M.M. Bossuyt, Pika Meško Brguljan, Guilaine Boursier, Christa M. Cobbaert, Michael Neumaier
Publikováno v:
Clinical chemistry and laboratory medicine. 61(4):608-626
The EU In-Vitro Diagnostic Device Regulation (IVDR) aims for transparent risk-and purpose-based validation of diagnostic devices, traceability of results to uniquely identified devices, and post-market surveillance. The IVDR regulates design, manufac
Autor:
Solveig Linko, Francisco Bernabeu-Andreu, Christos Kroupis, Florent Vanstapel, Marc H M Thelen, Marith van Schrojenstein Lantman, Mauro Panteghini, Duilio Brugnoni, Neda Milinković, Maria Lohmander, Guilaine Boursier, Cen standards, Ruth O'Kelly, Michel Vaubourdolle, Hikmet Can Çubukçu, Pika Meško Brguljan, Luděk Šprongl
Publikováno v:
Clinica Chimica Acta
Clinica Chimica Acta, 522, pp. 167-173
Clinica Chimica Acta, 522, 167-173
Clinica Chimica Acta, 522, pp. 167-173
Clinica Chimica Acta, 522, 167-173
The ISO 15189:2012 standard section 5.9.1 requires laboratories to review results before release, considering quality control, previous results, and clinical information, if any, and to issue documented procedures about it. While laboratory result re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8099648bc4ebd3e83d872e8076c6c2
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4077
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4077
Publikováno v:
Lung Cancer. 76:397-402
Introduction In lung cancer patients treated with chemotherapy, renal function is an important parameter to be monitored. Since measurement of renal function with either isotope or creatinine clearance is time consuming and expensive, we evaluated wh
Publikováno v:
Clinica Chimica Acta. 310:113-122
Background: In order to determine the effect of asthma on serum concentrations of cathepsins B, H and L, and stefins A and B, the circadian and concentration profiles were followed in steroid-independent and steroid-dependent asthmatics before and af
Publikováno v:
Clinica Chimica Acta. 300:83-95
The effect of asthma pathogenesis on serum cystatin C, a potent inhibitor of cysteine proteinases and a newly proposed marker of the renal function, has not been yet determined. The objectives were to determine the 24-h pattern of cystatin C and crea
Publikováno v:
Clinica Chimica Acta. 291:89-95
Publikováno v:
Pfl?gers Archiv European Journal of Physiology. 442:r204-r206
Cathepsin S (CS) has been proposed to be associated with asthma pathogenesis but its exact role is not established. In order to understand this proposed association our objective was to follow the 24-h concentration pattern of CS in sera from apparen
Publikováno v:
Peptides. 24(12)
Highly purified human brain cathepsin H (EC 3.4.22.16) was used to study its involvement in degradation of different brain peptides. Its action was determined to be selective. On Leu-enkephalin, dynorphin (1-6), dynorphin (1-13), alpha-neoendorphin,